Catalent, Inc. Announces First Quarter Fiscal Year 2023 Earnings Conference Webcast
businesswire.com
news
2022-10-17 00:00:00

October 17, 2022 05:12 PM Eastern Daylight Time SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, as well as consumer health products, today announced that it will release financial results for the first quarter of fiscal year 2023 ended September 30, 2022, before the market open on Tuesday, November 1, 2022. The Company's management will host a webcast to discuss the results at 8:15 a.
